Beovu Dosage

Generic name: brolucizumab-dbll
Dosage form: intravitreal injection
Drug class: Anti-angiogenic ophthalmic agents

Medically reviewed by  A Ras MD.

Adult Dosing

Dosage forms:  INJ (pre-filled syringe): 6 mg per 0.05 mL; INJ (vial): 6 mg per 0.05 mL

Special Note

[formulation clarification]

Info: nonproprietary name = brolucizumab-dbll

Age-related macular degeneration, neovascular

6 mg intravitreally q8-12wk

• Start: 6 mg intravitreally qmo x3 doses

Diabetic macular edema

6 mg intravitreally q8-12wk

• Start: 6 mg intravitreally q6wk x5 doses

Renal dosing

[no adjustment]

• renal impairment: no adjustment

HD/PD: no adjustment; no supplement

Hepatic dosing

no adjustment

SRC: NLM .